Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
Treatment frequency varies depending on individual goals and professional guidance
23 in placebo MACE-5 (a broader 5-component composite): hazard ratio 0.82 (95% CI 0.551.22) Neither result is statistically significant
Ipamorelin has a favorable safety profile, and many users take it for extended periods (6+ months) under medical supervision
Mild cold sensitivity can indicate that your metabolic rate has decreased and your body is entering fat-utilization modeboth signs of successful GLP-1 action
TRIUMPH-2: Obesity with Type 2 Diabetes (July 2026) TRIUMPH-2 enrolled 1,152 adults with obesity or overweight and type 2 diabetes, randomized 1:1:1:1 to retatrutide 4mg, 9mg, 12mg, or placebo over 80 weeks
US$ 24.83
US$ 27.97
US$ 23.02
US$ 28.86
US$ 25.97
US$ 27.00
